Increased decidual mRNA expression levels of candidate maternal pre-eclampsia susceptibility genes are associated with clinical severity
Abstract
No abstract availableKeywords
Funding Information
- Royal Women's Hospital
- National Institutes of Health Grant (HD049847)
- University of Melbourne's Melbourne International Fee Remission Scholarship
- Obstetrics and Gynaecology
This publication has 54 references indexed in Scilit:
- Fetal ERAP2 variation is associated with preeclampsia in African Americans in a case-control studyBMC Medical Genetics, 2011
- Expression Profile of MicroRNAs and mRNAs in Human Placentas From Pregnancies Complicated by Preeclampsia and Preterm LaborReproductive Sciences, 2011
- A transcriptional profile of the decidua in preeclampsiaAmerican Journal of Obstetrics and Gynecology, 2011
- Gene Expression Profiling of Placentas Affected by Pre-EclampsiaJournal of Biomedicine and Biotechnology, 2010
- The ERAP2 gene is associated with preeclampsia in Australian and Norwegian populationsHuman Genetics, 2009
- Differential Placental Gene Expression in Severe PreeclampsiaPlacenta, 2009
- Altered Global Gene Expression in First Trimester Placentas of Women Destined to Develop PreeclampsiaPlacenta, 2009
- Differential placental gene expression in preeclampsiaAmerican Journal of Obstetrics and Gynecology, 2008
- GAPDH, 18S rRNA and YWHAZ are Suitable Endogenous Reference Genes for Relative Gene Expression Studies in Placental Tissues from Human Idiopathic Fetal Growth RestrictionPlacenta, 2008
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001